NABIL ITANI: Open Payments
NPI 1912009168 · TITUSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,307 in 114 payments from 23 companies in 2025. Trend: 2023 $2,543 · 2024 $2,668 · 2025 $2,307
Food & beverage: $2,307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $443 |
| AstraZeneca Pharmaceuticals LP | 9 | $285 |
| PFIZER INC. | 12 | $199 |
| Novo Nordisk Inc | 12 | $174 |
| Lilly USA, LLC | 8 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $163 |
| Exact Sciences Corporation | 6 | $135 |
| Phathom Pharmaceuticals, Inc. | 5 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $82 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
Products named: QULIPTA, Kerendia, AIRSUPRA, MOUNJARO, Cologuard Collection Kit, VRAYLAR, NURTEC ODT, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
